Dr. Benjamin Musher
Claim this profileBaylor College of Medicine
Studies Pancreatic Cancer
Studies Stomach Cancer
6 reported clinical trials
12 drugs studied
Area of expertise
1Pancreatic Cancer
Stage I
Stage II
Stage IV
2Stomach Cancer
Stage I
Stage II
Stage III
Affiliated Hospitals
Clinical Trials Benjamin Musher is currently running
Chemotherapy + Immunotherapy
for Pancreatic Cancer
This trial tests a combination of chemotherapy and immune therapy for patients with a specific type of pancreatic cancer. The goal is to improve surgery outcomes by shrinking the tumor and boosting the body's ability to fight cancer.
Recruiting1 award Phase 231 criteria
Chemoimmunotherapy
for Colon Cancer
This is a Phase II open-label trial of neoadjuvant immunochemotherapy with Atezolizumab and CAPOX followed by surgery and potentially adjuvant chemotherapy for patients with localized resectable pMMR adenocarcinoma of the colon with a target accrual of 28 patients. The investigators will explore if appropriately timed neoadjuvant CAPOX with anti-PD-L1 mAb (Atezolizumab) can be administered safely and feasibly, and that this combination will lead to improved clinical response associated with enhanced numbers of immune cells in surgically resected colon tumors. Patients will receive 4 cycles of atezolizumab in combination with 4 cycles of CAPOX (atezolizumab will be administered prior to chemotherapy) before standard of care surgical resection. Following surgery, patients still considered to be at high-risk of recurrence (per SOC guidelines) will receive further adjuvant chemotherapy (mFOLFOX6 or CAPOX), based on the discretion of the treating oncologist/investigator. Circulating tumor DNA (ctDNA) dynamic change status will be analyzed through collection of blood samples throughout different stages of the patient's neoadjuvant treatment regimen (baseline, pre-neoadjuvant therapy, mid-neoadjuvant, post-neoadjuvant therapy, and during postoperative period) as a marker of early read on efficacy. The end of the study for each patient enrolled will be at the 6 month postoperative visit. On Study Protocol: Patients will be followed up for an efficacy follow-up phase during the first 6 months after surgery (week 2 \& months 3, 6 visits). All assessments beyond the 6 month visit will be performed under standard of care surveillance office visits. Off Study Protocol: Thereafter they will enter a survival follow-up phase per standard of care protocols. Patients will be seen every 6 months starting at month 12 until month 36. All collection of research-specific assessments including whole blood, stool collection and quality of life questionnaires will be optional beyond the 6 month postop visit (months 12-36).
Recruiting1 award Phase 2
More about Benjamin Musher
Clinical Trial Related5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Benjamin Musher has experience with
- MultiTAA Specific T Cells
- Autologous DC Vaccine
- Canakinumab And Spartalizumab
- Dose -mFOLFIRINOX
- Gemcitabine
- Pamrevlumab
Breakdown of trials Benjamin Musher has run
Pancreatic Cancer
Stomach Cancer
Lung Carcinoma
Pancreatic Carcinoma
Pancreatic Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Benjamin Musher specialize in?
Benjamin Musher focuses on Pancreatic Cancer and Stomach Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage I patients, or patients who are Stage II.
Is Benjamin Musher currently recruiting for clinical trials?
Yes, Benjamin Musher is currently recruiting for 3 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Benjamin Musher has studied deeply?
Yes, Benjamin Musher has studied treatments such as multiTAA specific T cells, Autologous DC vaccine, Canakinumab and Spartalizumab.
What is the best way to schedule an appointment with Benjamin Musher?
Apply for one of the trials that Benjamin Musher is conducting.
What is the office address of Benjamin Musher?
The office of Benjamin Musher is located at: Baylor College of Medicine, Houston, Texas 77030-3411 United States. This is the address for their practice at the Baylor College of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.